Prokaryotic expression, in vitro folding, and molecular pharmacological characterization of the neuropeptide Y receptor type 2

Biotechnology Progress

Volumn 25, Issue 6, 2009, Pages 1732-1739

  Schmidt, Peter ^a,b   Lindner, Diana ^a   Montag, Cindy ^a   Berndt, Sandra ^a   Beck Sickinger, Annette G ^a   Rudolph, Rainer ^b   Huster, Daniel ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

E. coli; Gpcr; In vitro folding; Membrane protein expression; Receptor; Y2

Indexed keywords

DETERGENT SOLUTION; E. COLI; G PROTEIN COUPLED RECEPTORS; HIGH DENSITY FERMENTATIONS; HIGH LEVEL EXPRESSION; IN-VITRO; INCLUSION BODIES; MEMBRANE PROTEINS; NANOMOLAR RANGE; NEUROPEPTIDE Y; PHARMACOLOGICAL CHARACTERIZATION; PROKARYOTIC EXPRESSION; RADIOLIGANDS; RECOMBINANT EXPRESSION; REFOLDING; SINGLE-STEP PURIFICATION; SPECIFIC BINDING; STRUCTURE AND DYNAMICS;

ASSAYS; ESCHERICHIA COLI;

PROTEINS;

NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; BINDING COMPETITION; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; ESCHERICHIA COLI; GENETICS; HUMAN; METABOLISM; MICELLE; MOLECULAR GENETICS; PROTEIN BINDING; PROTEIN FOLDING;

AMINO ACID SEQUENCE; BINDING, COMPETITIVE; ESCHERICHIA COLI; HUMANS; MICELLES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEUROPEPTIDE Y; PROTEIN BINDING; PROTEIN FOLDING; RECEPTORS, NEUROPEPTIDE Y;

ESCHERICHIA COLI; PROKARYOTA;

EID: 73249140429     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1002/btpr.266     Document Type: Article

References (66)

1. Tate CG, Grisshammer R. Heterologous expression of G-protein-coupled receptors. Trends Biotechnol. 1996;14:426-430.
2. Watts, A. Solid-state NMR in drug design and discovery for membrane-embedded targets. Nat Rev Drug Discov. 2005;4: 555-568.
3. Drews, J. Drug discovery: a historical perspective. Science. 2000;287:1960-1964.
4. Fredholm BB, Hokfelt T, Milligan G. G-protein-coupled receptors: an update. Acta Physiol. 2007;190:3-7.
5. Schoneberg T, Schulz A, Gudermann T. The structural basis of G-protein-coupled receptor function and dysfunction in human diseases. Rev Physiol Biochem Pharmacol. 2002;144: 143-227.
6. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le TI, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M. Crystal structure of rhodopsin: a G proteincoupled receptor. Science. 2000;289:739-745.
7. Salom D, Lodowski DT, Stenkamp RE, Le Trong I, Golczak M, Jastrzebska B, Harris T, Ballesteros JA, Palczewski K. Crystal structure of a photoactivated deprotonated intermediate of rhodopsin. Proc Natl Acad Sci USA. 2006;103:16123-16128.
8. Scheerer P, Park JH, Hildebrand PW, Kim YJ, Krauss N, Choe HW, Hofmann KP, Ernst OP. Crystal structure of opsin in its G-protein-interacting conformation. Nature. 2008;455: 497-502.
9. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SGF, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC. High-resolution crystal structure of an engineered human beta(2)-adrenergic G protein-coupled receptor. Science. 2007;318:1258-1265.
10. Rosenbaum DM, Cherezov V, Hanson MA, Rasmussen SGF, Thian FS, Kobilka TS, Choi HJ, Yao XJ, Weis WI, Stevens RC, Kobilka BK. GPCR engineering yields high-resolution structural insights into beta(2)-adrenergic receptor function. Science. 2007;318:1266-1273.
11. Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, Henderson R, Leslie AGW, Tate CG, Schertler GFX. Structure of a beta(1)-adrenergic G-protein-coupled receptor. Nature. 2008;454:486-4U2.
12. Jaakola VP, Griffith MT, Hanson MA, Cherezov V, Chien EYT, Lane JR, IJzerman AP, Stevens RC. The 2.6 angstrom crystal structure of a human A(2A) adenosine receptor bound to an antagonist. Science. 2008;322:1211-1217.
13. Torres J, Stevens TJ, Samso M. Membrane proteins: the ''wild west'' of structural biology. Trends Biochem Sci. 2003;28: 137-144.
14. McCusker EC, Bane SE, O'Malley MA, Robinson AS. Heterologous GPCR expression: a bottleneck to obtaining crystal structures. Biotechnol Prog. 2007;23:540-547.
15. Sarramegna V, Muller I, Milon A, Talmont F. Recombinant G protein-coupled receptors from expression to renaturation: a challenge towards structure. Cell Mol Life Sci. 2006;63:1149-1164.
16. Harding PJ, Attrill H, Boehringer J, Ross S, Wadhams GH, Smith E, Armitage JP, Watts A. Constitutive dimerization of the g-protein coupled receptor, neurotensin receptor 1, reconstituted into phospholipid bilayers. Biophys J. 2009;96:964-973.
17. Yeliseev AA, Wong KK, Soubias O, Gawrisch K. Expression of human peripheral cannabinoid receptor for structural studies. Protein Sci. 2005;14:2638-2653.
18. Bane SE, Velasquez JE, Robinson AS. Expression and purification of milligram levels of inactive G-protein coupled receptors in E. coli. Protein Expr Purif. 2007;52:348-355.
19. Booth PJ. The trials and tribulations of membrane protein folding in vitro. Biochim Biophys Acta. 2002;1610:51-56.
20. Lilie H, Schwarz E, Rudolph R. Advances in refolding of proteins produced in E. coli. Curr Opin Biotechnol. 1998;9: 497-501.
21. De Bernardez Clark E, Schwarz E, Rudolph R. Inhibition of aggregation side reactions during in vitro protein folding. Methods Enzymol. 1999;309:217-236.
22. Baneres JL, Martin A, Hullot P, Girard JP, Rossi JC, Parello J. Structure-based analysis of GPCR function: conformational adaptation of both agonist and receptor upon leukotriene B-4 binding to recombinant BLT1. J Mol Biol. 2003;329:801-814.
23. Kiefer H, Maier K, Vogel R. Refolding of G-protein-coupled receptors from inclusion bodies produced in Escherichia coli. Biochem Soc Trans. 1999;27:908-912.
24. Rogl H, Kosemund K, Kuhlbrandt W, Collinson I. Refolding of Escherichia coli produced membrane protein inclusion bodies immobilised by nickel chelating chromatography. FEBS Lett. 1998;432:21-26.
25. Pautsch A, Vogt I, Model K, Siebold C, Schulz GE. Strategy for membrane protein crystallization exemplified with OmpA and OmpX. Proteins: Struct Funct Genet. 1999;34:167-172.
26. Park SH, Prytulla S, De Angelis AA, Brown JM, Kiefer H, Opella SJ. High-resolution NMR spectroscopy of a GPCR in aligned bicelles. J Am Chem Soc. 2006;128:7402-7403.
27. Hiller S, Garces RG, Malia TJ, Orekhov VY, Colombini M, Wagner G. Solution structure of the integral human membrane protein VDAC-1 in detergent micelles. Science. 2008;321:1206-1210.
28. Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T, Westfall T XVI. International union of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev. 1998;50:143-150.
29. Parker SL, Balasubramaniam A. Neuropeptide YY2 receptor in health and disease. Br J Pharmacol. 2008;153:420-431.
30. Jinde S, Masui A, Morinobu S, Noda A, Kato N. Differential changes in messenger RNA expressions and binding sites of neuropeptide Y Y1, Y2 and Y5 receptors in the hippocampus of an epileptic mutant rat: Noda epileptic rat. Neuroscience. 2002;115:1035-1045.
31. Inui A. Neuropeptide Y feeding receptors: are multiple subtypes involved? Trends Pharmacol Sci. 1999;20:43-46.
32. Beck-Sickinger AG, Wieland HA, Wittneben H, Willim KD, Rudolf K, Jung G. Complete L-alanine scan of neuropeptide Y reveals ligands binding to Y1 and Y2 receptors with distinguished conformations. Eur J Biochem. 1994;225:947-958.
33. Rudolph R, Lilie H. In vitro folding of inclusion body proteins. FASEB J. 1996;10:49-56.
34. Grauschopf U, Lilie H, Honold K, Wozny M, Reusch D, Esswein A, Schafer W, Rucknagel KP, Rudolph R. The N-terminal fragment of human parathyroid hormone receptor 1 constitutes a hormone binding domain and reveals a distinct disulfide pattern. Biochemistry. 2000;39:8878-8887.
35. Gnoth S, Jenzsch M, Simutis R, Lubbert A. Control of cultivation processes for recombinant protein production: a review. Bioprocess Biosyst Eng. 2008;31:21-39.
36. Gnoth S, Jenzsch M, Simutis R, Lubbert A. Product formation kinetics in genetically modified E. coli bacteria: inclusion body formation. Bioprocess Biosyst Eng. 2008;31:41-46.
37. Wagner S, Klepsch MM, Schlegel S, Appel A, Draheim R, Tarry M, Hogbom M, van Wijk KJ, Slotboom DJ, Persson JO, de Gier JW. Tuning Escherichia coli for membrane protein overexpression. Proc Natl Acad Sci USA. 2008;105:14371-14376.
38. Grisshammer R, Tucker J. Quantitative evaluation of neurotensin receptor purification by immobilized metal affinity chromatography. Protein Expr Purif. 1997;11:53-60.
39. Damian M, Perino S, Polidori A, Martin A, Serre L, Pucci B, Baneres JL. New tensio-active molecules stabilize a human G protein-coupled receptor in solution. FEBS Lett. 2007;581: 1944-1950.
40. Buchner J, Rudolph R. Routes to active proteins from transformed microorganisms. Curr Opin Biotechnol. 1991;2:532-538.
41. Krepkiy D, Wong K, Gawrisch K, Yeliseev A. Bacterial expression of functional, biotinylated peripheral cannabinoid receptor CB2. Protein Expr Purif. 2006;49:60-70.
42. Harding PJ, Attrill H, Ross S, Koeppe JR, Kapanidis AN, Watts A. Neurotensin receptor Type 1: Escherichia coli expression, purification, characterization and biophysical study. Biochem Soc Trans. 2007;35:760-763.
43. Sawano H, Koumoto Y, Ohta K, Sasaki Y, Segawa S, Tachibana H. Efficient in vitro folding of the three-disulfide derivatives of hen lysozyme in the presence of glycerol. FEBS Lett. 1992;303:11-14.
44. Rozema D, Gellman SH. Artificial chaperone-assisted refolding of denatured-reduced lysozyme: modulation of the competition between renaturation and aggregation. Biochemistry. 1996;35: 15760-15771.
45. Koglin N, Lang M, Rennert R, Beck-Sickinger AG. Facile and selective nanoscale labeling of peptides in solution by using photolabile protecting groups. J Med Chem. 2003;46:4369-4372.
46. Merten N, Lindner D, Rabe N, Rompler H, Morl K, Schoneberg T, Beck-Sickinger AG. Receptor subtype-specific docking of Asp(6.59) with C-terminal arginine residues in Y receptor ligands. J Biol Chem. 2007;282:7543-7551.
47. Allen SP, Polazzi JO, Gierse JK, Easton AM. Two novel heat shock genes encoding proteins produced in response to heterologous protein expression in Escherichia coli. J Bacteriol. 1992;174:6938-6947.
48. Marston FA. The purification of eukaryotic polypeptides synthesized in Escherichia coli. Biochem J. 1986;240:1-12.
49. le Maire M, Champeil P, Moller JV. Interaction of membrane proteins and lipids with solubilizing detergents. Biochim Biophys Acta. 2000;1508:86-111.
50. O'Malley MA, Lazarova T, Britton ZT, Robinson AS. Highlevel expression in Saccharomyces cerevisiae enables isolation and spectroscopic characterization of functional human adenosine A(2)a receptor. J Struct Biol. 2007;159:166-178.
51. Shi CH, Shin YO, Hanson J, Cass B, Loewen MC, Durocher Y. Purification and characterization of a recombinant G-proteincoupled receptor, Saccharomyces cerevisiae Ste2p, transiently expressed in HEK293 EBNA1 cells. Biochemistry. 2005;44: 15705-15714.
52. Kobilka BK. Amino and carboxyl terminal modifications to facilitate the production and purification of a G protein-coupled receptor. Anal Biochem. 1995;231:269-271.
53. Kiefhaber T, Rudolph R, Kohler HH, Buchner J. Protein aggregation in vitro and in vivo: a quantitative model of the kinetic competition between folding and aggregation. Biotechnology. 1991;9:825-829.
54. Hjelmeland LM, Nebert DW, Osborne JC. Sulfobetaine derivatives of bile-acids non-denaturing surfactants for membrane biochemistry. Anal Biochem. 1983;130:72-82.
55. Hiniker A, Bardwell JCA. Disulfide bond isomerization in prokaryotes. Biochemistry. 2003;42:1179-1185.
56. Bader R, Zerbe O. Are hormones from the neuropeptide Y family recognized by their receptors from the membrane-bound state? Chembiochem. 2005;6:1520-1534.
57. Thomas L, Scheidt HA, Bettio A, Huster D, Beck-Sickinger AG, Arnold K, Zschornig O. Membrane interaction of neuropeptide Y detected by EPR and NMR spectroscopy. Biochim Biophys Acta. 2005;1714:103-113.
58. Thomas L, Scheidt HA, Bettio A, Beck-Sickinger AG, Huster D, Zschornig O. Membrane interaction of NPY in the presence of negatively charged and zwitterionic phospholipids. Eur Biophys J. 2009;38:663-677.
59. Murray D, Ben-Tal N, Honig B, McLaughlin S. Electrostatic interaction of myristoylated proteins with membranes: simple physics, complicated biology. Structure. 1997;5:985-989.
60. Etzkorn M, Martell S, Andronesi OC, Seidel K, Engelhard M, Baldus M. Secondary structure, dynamics, and topology of a seven-helix receptor in native membranes, studied by solid-state NMR spectroscopy. Angew Chem Int Ed Engl. 2007;46:459-462.
61. Lorch M, Fahem S, Kaiser C, Weber I, Mason AJ, Bowie JU, Glaubitz C. How to prepare membrane proteins for solid-state NMR: a case study on the alpha-helical integral membrane protein diacylglycerol kinase from E. coli. Chembiochem. 2005;6: 1693-1700.
62. Huster D. Investigations of the structure and dynamics of membrane-associated peptides by magic angle spinning NMR. Prog Nucl Magn Reson Spectrosc. 2005;46:79-107.
63. Luca S, Heise H, Baldus M. High-resolution solid-state NMR applied to polypeptides and membrane proteins. Acc Chem Res. 2003;36:858-865.
64. Opella SJ, Marassi FM. Structure determination of membrane proteins by NMR spectroscopy. Chem Rev. 2004;104:3587-3606.
65. Lopez JJ, Shukla AK, Reinhard C, Schwalbe H, Michel H, Glaubitz C. The structure of the neuropeptide bradykinin bound to the human G-protein coupled receptor bradykinin B2 as determined by solid-state NMR spectroscopy. Angew Chem Int Ed Engl. 2008;47:1668-1671.
66. Luca S, White JF, Sohal AK, Filippov DV, van Boom JH, Grisshammer R, Baldus M. The conformation of neurotensin bound to its G protein-coupled receptor. Proc Natl Acad Sci USA. 2003;100:10706-10711.